Why Cooper Companies Stock Sank by 13% Today
The stock of medical device specialist Cooper Companies (NASDAQ: COO) was hurting on the second-to-last trading day of the week. It sank to a 13% loss on the day, following the publication of the company's latest quarterly earnings release. In contrast, the S 500 (SNPINDEX: ^GSPC) successfully treaded water, with a 0.3% increase.
Cooper's third quarter of fiscal 2025 saw the company book slightly over $1.06 billion in revenue, representing a year-over-year improvement of 6%. Of its two divisions, the larger one, CooperVision (CVI), matched that percentage increase by contributing more than $718 million to the top line. CooperSurgical's (CSI) sales, meanwhile, rose 4% to almost $342 million.
Image source: Getty Images.
Source Fool.com
